Polaris Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-225,779
Closed -$60.9M 109
2021
Q4
$60.9M Sell
225,779
-3,026
-1% -$749K 1.97% 20
2021
Q3
$55.3M Hold
228,805
1.76% 19
2021
Q2
$54.2M Buy
228,805
+2,910
+1% +$663K 1.75% 23
2021
Q1
$53.8M Sell
225,895
-36,783
-14% -$7.38M 1.76% 21
2020
Q4
$45.9M Buy
262,678
+10,360
+4% +$1.79M 1.73% 26
2020
Q3
$40.8M Sell
252,318
-968
-0.4% -$153K 2.01% 16
2020
Q2
$36.1M Buy
253,286
+5,820
+2% +$805K 1.79% 17
2020
Q1
$26.9M Buy
+247,466
New +$35.7M 1.62% 20

Other funds holding LH

Polaris Capital Management's LH Position: Q1 2022 in Review

Polaris Capital Management sold out of Labcorp (LH) in Q1 2022, closing a stake of 225,779 shares — an estimated $60.9M sold.

Polaris Capital Management first reported a position in LH in Q1 2020 and held it in 8 quarters. The position peaked at $60.9M in Q4 2021. 1,033 funds tracked by Wall St. Rank hold LH as of Q1 2022.

  • Polaris Capital Management reported no remaining Labcorp position as of Q1 2022 after selling out during the quarter.
  • Polaris Capital Management sold 225,779 Labcorp shares in Q1 2022, an estimated $60.9M.
  • Polaris Capital Management first reported a position in Labcorp in Q1 2020 and held it in 8 quarters.
  • Polaris Capital Management's Labcorp position peaked at $60.9M in Q4 2021.
  • 1,033 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on Polaris Capital Management's 13F filing for Q1 2022, filed 11 May 2022.